Argenx
ARGX
$920.27
Share price
2.77%
Change (1 day)
58.80%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Market capitalization of Argenx (ARGX)
Market cap: A$56.67 Billion
As of April 2025 Argenx has a market cap of A$56.67 Billion. This makes Argenx the world's 547th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Argenx from 2014 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$56.67 B | -5.88% |
| 2024 | A$60.21 B | 81.78% |
| 2023 | A$33.12 B | 7.55% |
| 2022 | A$30.79 B | 21.41% |
| 2021 | A$25.36 B | 39.11% |
| 2020 | A$18.23 B | 85.61% |
| 2019 | A$9.82 B | 97.4% |
| 2018 | A$4.97 B | 93.8% |
| 2017 | A$2.56 B | |
| 2014 | A$0.17 B |
End of Day market cap according to different sources
On Apr 9th, 2025 the market cap of Argenx was reported to be:
